FTC Approves Final Order Settling Charges That Watson Pharmaceuticals, Inc.'s Acquisition of Actavis Inc. Would Have Been Anticompetitive
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Watson Pharmaceuticals, Inc.’s proposed acquisition of Actavis Inc. would have been...